COF
COF: RASKIND PETER E discloses a sale
RASKIND PETER E reported Sale in CAPITAL ONE FINANCIAL CORP: 1260 units of Common Stock, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
COF
RASKIND PETER E reported Sale in CAPITAL ONE FINANCIAL CORP: 1260 units of Common Stock, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
NPB
Long Joseph B reported Grant or award in NORTHPOINTE BANCSHARES INC: 10000 units of Restricted stock units (derivative), dated 2026-11-10. The full Form 4 contains 1 transaction entry.
AIZ
Lumsden Ryan reported Sale in ASSURANT, INC.: 3901 units of Common Stock, dated 2026-11-10. The full Form 4 contains 1 transaction entry.
ZVIA
Lee David J. reported Sale in Zevia PBC: 179589 units of Class A Common Stock, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
FNF
HAGERTY THOMAS M reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
IT
Genovese Yvonne reported Sale in GARTNER INC: 524 units of Common Stock, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
TEVA
BRAILER DAVID J reported Grant or award in TEVA PHARMACEUTICAL INDUSTRIES LTD: 3326 units of Restricted Share Units (derivative), dated 2026-11-10. The full Form 4 contains 1 transaction entry.
INTA
Harris Nancy L reported Sale in Intapp, Inc.: 1201 units of Common Stock, dated 2026-11-09. The full Form 4 contains 3 transaction entries.
NVCR
Brackmann Christoph reported Sale in NovoCure Ltd: 7343.00 units of Ordinary Shares, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
MPLX
HAGEDORN CARL KRISTOPHER reported Sale in MPLX LP: 3512 units of Common Units (Limited Partner Interests), dated 2026-11-10. The full Form 4 contains 1 transaction entry.
FNF
LANE DANIEL D reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
NVCR
Paravasthu Mukund reported Sale in NovoCure Ltd: 3079.00 units of Ordinary Shares, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
AEIS
Donaghey John reported Sale in ADVANCED ENERGY INDUSTRIES INC: 3238 units of Common Stock, dated 2026-11-11. The full Form 4 contains 1 transaction entry.
FNF
Murren Heather Hay reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
TEVA
Bergwerk Dov reported Grant or award in TEVA PHARMACEUTICAL INDUSTRIES LTD: 9433 units of Restricted Share Units (derivative), dated 2026-11-10. The full Form 4 contains 1 transaction entry.
FNF
Morgan Sandra Douglass reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
ZVIA
Ruberti Alexandre reported Purchase in Zevia PBC: 81300 units of Class A Common Stock, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
SELF
Zachary William Chester reported 2,748 shares of Common Stock in Global Self Storage, Inc. as grants or awards dated 2026-11-10. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
IRLA
Militello John reported Grant or award in IRulya Therapeutics Inc.: 80000 units of Common Stotck, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
IRLA
Bonuccelli Catherine M. reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.
IRLA
PATTERSON LEONE D reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.
FNF
Rood John D reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
IRLA
Valentine James Elwood reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.
IRLA
Wise John Drayton reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.